Reaction
Progressive External Ophthalmoplegia reporting signals
As of the last recalculation, Progressive External Ophthalmoplegia appears in 129 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is RITONAVIR 100 MG (PRR 5,791.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ritonavir 100 Mg | 104 | 5,791.8 | 5,832.6 |
| Abacavir Sulfate | 94 | 5,735.5 | 5,791.7 |
| Ritonavir | 114 | 5,406.2 | 5,427.5 |
| Zidovudine | 100 | 5,363.9 | 5,404.6 |
| Nevirapine | 81 | 3,891.6 | 3,927.1 |
| Darunavir | 92 | 3,419.4 | 3,440.5 |
| Lamivudine Oral | 101 | 2,964.1 | 2,976.1 |
| Lopinavir And Ritonavir | 82 | 2,677.4 | 2,693.8 |
| Lamivudine | 101 | 2,426.4 | 2,434.4 |
| Efavirenz | 72 | 2,356.9 | 2,372.3 |
| Tenofovir Disoproxil Fumarate Tablets | 50 | 1,525.1 | 1,534.0 |
| Raltegravir | 68 | 1,404.1 | 1,410.0 |
| Tenofovir Disoproxil Fumarate | 86 | 1,257.4 | 1,260.7 |
| Atazanavir | 16 | 204.9 | 205.2 |